ClinicalTrials.govpublic full text
A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma
glioblastoma, recurrent glioblastoma, multiple agents, immunotherapy, chemotherapy, brain and nervous system, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 881066
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.